1215650-08-0
1215650-08-0
Chemical Structure
Butamirate-d5 citrate
- CAS. Nr.: 1215650-08-0
- Formula:C24H32D5NO10
- Molecular Weight:504.58
IUPAC Name: 2-(2-(diethylamino)ethoxy)ethyl 2-phenylbutanoate-3,3,4,4,4-d5 2-hydroxypropane-1,2,3-tricarboxylate
InChIKey: JVKMHUAWFDGPTF-UHBAQTEVSA-N
SMILES: OC(CC(C(O)=O)(O)CC(O)=O)=O.CCN(CC)CCOCCOC(C(C1=CC=CC=C1)C([2H])([2H])C([2H])([2H])[2H])=O
Biological Activity: Butamirate-d5 citrate is the deuterium labeled Butamirate citrate[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Butamirate-d5 citrate | Butamirate-d5 citrate is the deuterium labeled Butamirate citrate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Butamirate citrate (Standard) | ≥98% | Butamirate citrate (Standard) is the analytical standard of Butamirate citrate (HY-118545A). This product is intended for research and analytical applications. Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Butamirate citrate | 99.88% | Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
